$SBET
SharpLink Gaming, Inc. Stock $sbet

$sbet Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012028 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$975.9K	$4.953M	$4.953M
YoY Change	-20.83%		41.91%
Cost Of Revenue	$688.7K	$3.420M	$3.420M
YoY Change	-18.27%		57.33%
Gross Profit	$287.2K	$1.533M	$1.533M
YoY Change	-26.37%		16.45%
Gross Profit Margin	29.43%	30.95%	30.95%
Selling, General & Admin	$1.972M	$7.961M	$7.961M
YoY Change	-3.58%		-26.78%
% of Gross Profit	686.63%	519.43%	519.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.202K	-$493.1K	$10.29K
YoY Change	-24.1%		-1.81%
% of Gross Profit	0.77%	-32.17%	0.67%
Operating Expenses	$1.972M	$7.961M	$10.43M
YoY Change	-3.58%		-33.16%
Operating Profit	-$1.685M	-$6.428M	-$8.893M
YoY Change	1.79%		-37.74%
Interest Expense	$324.2K	-$2.327M	$1.150M
YoY Change	44.81%		953.76%
% of Operating Profit
Other Income/Expense, Net	-$70.27K	-$12.61K	-$2.340M
YoY Change	-85.15%		-1442.82%
Pretax Income	-$1.755M	-$11.23M	-$11.23M
YoY Change	-17.54%		-20.38%
Income Tax	$5.674K	$15.71K	$15.71K
% Of Pretax Income
Net Earnings	$12.35M	-$14.24M	-$14.24M
YoY Change	-537.37%		-6.5%
Net Earnings / Revenue	1265.48%	-287.58%	-287.58%
Basic Earnings Per Share	$3.96		-$5.17
Diluted Earnings Per Share	$3.36	-$5.15	-$5.17
COMMON SHARES
Basic Shares Outstanding	3.287M shares		2.761M shares
Diluted Shares Outstanding	3.582M shares		2.761M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.487M	$2.487M
YoY Change			-93.67%
Cash & Equivalents	$4.014M	$2.487M	$2.487M
Short-Term Investments
Other Short-Term Assets		$0.00	$68.19M
YoY Change			403.61%
Inventory
Prepaid Expenses
Receivables	$364.0K	$415.1K	$427.1K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$5.372M	$71.10M	$71.10M
YoY Change	-89.02%	31.89%	31.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.309K	$8.792K	$8.790K
YoY Change	-96.8%	-59.82%	-96.97%
Goodwill
YoY Change
Intangibles	$16.88K	$168.1K
YoY Change		-79.95%
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change
Total Long-Term Assets	$25.19K	$176.9K	$176.9K
YoY Change	-99.77%	-98.41%	-98.41%
TOTAL ASSETS
Total Short-Term Assets	$5.372M	$71.10M	$71.10M
Total Long-Term Assets	$25.19K	$176.9K	$176.9K
Total Assets	$5.397M	$71.28M	$71.28M
YoY Change	-91.01%	9.59%	9.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$834.1K	$1.464M
YoY Change		21.03%	-31.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$6.346M	$6.346M
YoY Change			54.03%
Long-Term Debt Due		$645.6K	$5.041M
YoY Change			394.25%
Total Short-Term Liabilities	$2.544M	$79.25M	$79.25M
YoY Change	-95.43%	34.52%	34.52%
LONG-TERM LIABILITIES
Long-Term Debt		$1.425M	$1.425M
YoY Change		-30.94%	-51.37%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$0.00	$1.425M	$1.425M
YoY Change	-100.0%	-30.94%	-54.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.544M	$79.25M	$79.25M
Total Long-Term Liabilities	$0.00	$1.425M	$1.425M
Total Liabilities	$2.544M	$80.68M	$80.68M
YoY Change	-95.66%	30.01%	30.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$75.56M	-$87.86M
YoY Change		19.43%
Common Stock	$1.145M	$1.145M
YoY Change		112.98%
Preferred Stock		$3.934K
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.852M	$2.500M	-$9.400M
YoY Change
Total Liabilities & Shareholders Equity	$5.397M	$71.28M	$71.28M
YoY Change	-91.01%	9.59%	9.58%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$12.35M	-$14.24M	-$14.24M
YoY Change	-537.37%		-6.5%
Depreciation, Depletion And Amortization	$2.202K	-$493.1K	$10.29K
YoY Change	-24.1%		-1.81%
Cash From Operating Activities	-$19.29M	-$5.630M	$582.9K
YoY Change	28.91%		-109.82%
INVESTING ACTIVITIES
Capital Expenditures	$1.719K	-$558.2K	$12.15K
YoY Change	-6.22%		-6.91%
Acquisitions
YoY Change
Other Investing Activities		-$746.0K	-$746.0K
YoY Change			-101.54%
Cash From Investing Activities	-$18.71M	-$187.7K	-$1.032M
YoY Change	7659.21%		-102.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$18.24M	1.922M	$9.785M
YoY Change	-530.1%		265.74%
NET CHANGE
Cash From Operating Activities	-$19.29M	-5.630M	$582.9K
Cash From Investing Activities	-$18.71M	-187.7K	-$1.032M
Cash From Financing Activities	-$18.24M	1.922M	$9.785M
Net Change In Cash	-$56.25M	-3.896M	$9.336M
YoY Change	412.89%		-79.27%
FREE CASH FLOW
Cash From Operating Activities	-$19.29M	-$5.630M	$582.9K
Capital Expenditures	$1.719K	-$558.2K	$12.15K
Free Cash Flow	-$19.30M	-$5.072M	$570.7K
YoY Change	28.91%		-109.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001981535
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	SBET	Gain Loss In Fair Value Of Convertible Debenture GainLossInFairValueOfConvertibleDebenture		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2022	SBET	Change In Fair Value Of Convertible Debenture ChangeInFairValueOfConvertibleDebenture		usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2022	SBET	Accrued Interest On Convertible Debenture AccruedInterestOnConvertibleDebenture		usd
CY2023	SBET	Writeoff Of Amounts Related To Acquisition WriteoffOfAmountsRelatedToAcquisition		usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash		usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash		usd
CY2023	SBET	Issuance Of Ordinary Shares In Sportshub Gaming Network Merger IssuanceOfOrdinarySharesInSportshubGamingNetworkMerger		usd
CY2023	SBET	Issuance Of Ordinary Shares For Advisory Services IssuanceOfOrdinarySharesForAdvisoryServices		usd
CY2022	SBET	Shares Issued For Services Provided SharesIssuedForServicesProvided		usd
CY2022	SBET	Deemed Dividends DeemedDividends		usd
CY2022	SBET	Discount On Convertible Debenture And Purchase Warrant DiscountOnConvertibleDebentureAndPurchaseWarrant		usd
CY2022	SBET	Shares Issued For Cashless Exercised Warrants SharesIssuedForCashlessExercisedWarrants		usd
CY2022	SBET	Shares Issued Previously Reserved For Future Issuance SharesIssuedPreviouslyReservedForFutureIssuance		usd
CY2023	SBET	Dividend Due To Forgiveness Of Intercompany Loan DividendDueToForgivenessOfIntercompanyLoan		usd
CY2022	SBET	Extension Of Maturity Of Operating Lease Liability ExtensionOfMaturityOfOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q4	SBET	Weighted Average Grant Date Fair Value WeightedAverageGrantDateFairValue
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	SBET	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised
CY2022	SBET	Weighted Average Grant Date Fair Value Expired WeightedAverageGrantDateFairValueExpired
CY2022Q4	SBET	Weighted Average Grant Date Fair Value WeightedAverageGrantDateFairValue
CY2023Q4	SBET	Weighted Average Grant Date Fair Value Exercisable WeightedAverageGrantDateFairValueExercisable
CY2022Q4	SBET	Deferred Tax Assets Capitializations DeferredTaxAssetsCapitializations		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023	SBET	Income Tax Reconciliation Nondeductible Goodwill Impairment IncomeTaxReconciliationNondeductibleGoodwillImpairment		usd
CY2022	SBET	Income Tax Reconciliation Nondeductible Goodwill Impairment IncomeTaxReconciliationNondeductibleGoodwillImpairment		usd
CY2022	SBET	Income Tax Reconciliation Nondeductible Debt Expenses IncomeTaxReconciliationNondeductibleDebtExpenses		usd
CY2022	SBET	Income Tax Reconciliation Financial Statements True Up IncomeTaxReconciliationFinancialStatementsTrueUp		usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41962
CY2023	dei	Entity Registrant Name EntityRegistrantName	SHARPLINK GAMING, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-4752260
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	333 Washington Avenue North
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 104
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
CY2023	dei	City Area Code CityAreaCode	612
CY2023	dei	Local Phone Number LocalPhoneNumber	293-0619
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	SBET
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	9643045	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3286608	shares
CY2023	dei	Auditor Firm AuditorFirmId	677
CY2023	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2023	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2023Q4	us-gaap	Cash Cash	2487481	usd
CY2022Q4	us-gaap	Cash Cash	1381344	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	415119	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	440873	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	12000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	12000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	383295	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	505905	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	67805379	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	51570443	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	71103274	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	53910565	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8792	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21881	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	168112	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	838463	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1615167	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	8659415	usd
CY2023Q4	us-gaap	Assets Assets	71280178	usd
CY2022Q4	us-gaap	Assets Assets	65045491	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1463699	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1466381	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6345978	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	645571	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	620173	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	283335	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q4	SBET	Warrant Discount WarrantDiscount	831746	usd
CY2022Q4	SBET	Warrant Discount WarrantDiscount	0	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	299648	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	0	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4395753	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	66396883	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	56824479	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	79247884	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	58911033	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7155	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6206	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1424908	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2063243	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1078492	usd
CY2023Q4	us-gaap	Liabilities Liabilities	80679947	usd
CY2022Q4	us-gaap	Liabilities Liabilities	62058974	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2863734	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2863734	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2688541	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2688541	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	572770	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	537731	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	90	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	90	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	29000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	29000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	77909981	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76039604	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87857456	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73565641	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9399769	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2986517	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71280178	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65045491	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4952725	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3489948	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3420062	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2173835	usd
CY2023	us-gaap	Gross Profit GrossProfit	1532663	usd
CY2022	us-gaap	Gross Profit GrossProfit	1316113	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7961133	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10872951	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2464732	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4726000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10425865	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	15598951	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8893202	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-14282838	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	53493	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	33402	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12606	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	250000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1150341	usd
CY2022	us-gaap	Interest Expense InterestExpense	109165	usd
CY2023	SBET	Gain Loss In Fair Value Of Convertible Debenture GainLossInFairValueOfConvertibleDebenture	-1230234	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2339688	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	174237	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11232890	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14108601	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15708	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12955	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11248598	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14095646	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2994584	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1137732	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-14243182	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-15233378	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-11299092	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-11299092	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-14104508	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-14104508	usd
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-2994584	usd
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-2994584	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1137732	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-1137732	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14293676	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14293676	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15242240	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15242240	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2760970	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2760970	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487960	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2487960	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.09
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.09
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-5.67
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-5.67
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.08
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.08
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.46
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.46
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.17
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.17
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.13
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14191456	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15233378	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2486152	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11248598	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14095646	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2994584	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1137732	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-14243182	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15233378	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	107414	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	912248	usd
CY2023	SBET	Change In Fair Value Of Convertible Debenture ChangeInFairValueOfConvertibleDebenture	1230234	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	459148	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10714	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8073	usd
CY2023	SBET	Accrued Interest On Convertible Debenture AccruedInterestOnConvertibleDebenture	299648	usd
CY2023	SBET	Amortization Of Prepaid Stock AmortizationOfPrepaidStock	129000	usd
CY2022	SBET	Amortization Of Prepaid Stock AmortizationOfPrepaidStock	43000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6206	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	81323	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	261373	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1940691	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12607	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2594	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2464732	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4726000	usd
CY2022	SBET	Writeoff Of Amounts Related To Acquisition WriteoffOfAmountsRelatedToAcquisition	-303523	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25754	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-68320	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6390	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	253844	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1344158	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	37819	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-76600	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7910996	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8047277	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	8493883	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	2109891	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	582887	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5937386	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12147	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13048	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	273999	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	22747	usd
CY2022	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	4493	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	388000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-286146	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-419302	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-745951	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	48721370	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1032097	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	48302068	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4000000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	419048	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6350000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3250000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	620173	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	549225	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7500	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	25432	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9303279	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2675343	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	481575	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9784854	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2675343	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9335644	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45040025	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	51105486	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6065461	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	60441130	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	51105486	usd
CY2023	SBET	Net Cash Provided By Used In Discontinued Operation NetCashProvidedByUsedInDiscontinuedOperation	-57953649	usd
CY2022	SBET	Net Cash Provided By Used In Discontinued Operation NetCashProvidedByUsedInDiscontinuedOperation	-49724142	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2487481	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1381344	usd
CY2023Q4	us-gaap	Cash Cash	2487481	usd
CY2022Q4	us-gaap	Cash Cash	1381344	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2487481	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1381344	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	485531	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	109165	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	86320	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	19916	usd
CY2022	SBET	Issuance Of Ordinary Shares In Sportshub Gaming Network Merger IssuanceOfOrdinarySharesInSportshubGamingNetworkMerger	1370287	usd
CY2022	SBET	Issuance Of Ordinary Shares For Advisory Services IssuanceOfOrdinarySharesForAdvisoryServices	172000	usd
CY2023	SBET	Shares Issued For Services Provided SharesIssuedForServicesProvided	48300	usd
CY2023	SBET	Deemed Dividends DeemedDividends	48633	usd
CY2023	SBET	Discount On Convertible Debenture And Purchase Warrant DiscountOnConvertibleDebentureAndPurchaseWarrant	1574229	usd
CY2023	SBET	Shares Issued For Cashless Exercised Warrants SharesIssuedForCashlessExercisedWarrants	24296	usd
CY2023	SBET	Shares Issued Previously Reserved For Future Issuance SharesIssuedPreviouslyReservedForFutureIssuance	4743	usd
CY2023	SBET	Dividends On Preferred Stock DividendsOnPreferredStock	1861	usd
CY2022	SBET	Dividends On Preferred Stock DividendsOnPreferredStock	8862	usd
CY2022	SBET	Dividend Due To Forgiveness Of Intercompany Loan DividendDueToForgivenessOfIntercompanyLoan	2039000	usd
CY2023	SBET	Extension Of Maturity Of Operating Lease Liability ExtensionOfMaturityOfOperatingLeaseLiability	77742	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	48859270	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	186712	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	1916932	usd
CY2022Q4	SBET	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Operating Rightofuse Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOperatingRightofuseAsset	95793	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	11953	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	7358703	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	284345	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	42600997	usd
CY2022Q4	SBET	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Prize Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPrizeLiability	5056120	usd
CY2022Q4	SBET	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Deb BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDeb	5387851	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	106703	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	3574285	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	48775	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	1370287	usd
CY2023Q4	SBET	Common Stock Par Or Stated Value Per Share One CommonStockParOrStatedValuePerShareOne	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	572770	usd
CY2023Q4	SBET	Common Stock Par Or Stated Value Per Share One CommonStockParOrStatedValuePerShareOne	0.0001
CY2023Q4	SBET	Common Stock Value One CommonStockValueOne	286	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	SBET	Adjustments Preferred Stock Value AdjustmentsPreferredStockValue	2	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	572484	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	3936	usd
CY2023Q4	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	3934	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zGTiDAa8keY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zFdnOex8nnX1">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in prior periods have been reclassified to reflect the impact of the discontinued operations treatment in order to conform to the current period presentation. <i>See Note 3.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Share Price SharePrice	0.60
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26881244	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26881244	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2688541	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2688541	shares
CY2023Q2	us-gaap	Share Price SharePrice	0.06
CY2023Q2	us-gaap	Share Price SharePrice	0.02
CY2023Q2	us-gaap	Share Price SharePrice	0.60
CY2023Q2	us-gaap	Share Price SharePrice	0.20
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_z6XZY886uQP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zhSl8gvn03bb">Concentrations of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and restricted cash are deposited with major banks in the United States and Israel. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, the FDIC limit per bank is $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z6Qvlv5oenbh" title="FDIC insured limit">250,000</span>. Any loss incurred or a lack of access to such funds above the FDIC limit could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_zoAQOzi0RmD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following represents the cash on hand at December 31, 2023 by banking institution and does not include any reduction for the FDIC insured limit of $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zn68nXkV4q08" title="FDIC insured limit">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zPu891rKR7T1" style="display: none">Schedule of Cash and Restricted Cash</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Bank</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20231231_zW1DV33uRQqa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalents_iI_hus-gaap--RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis__custom--PlatinumBankMember_zk6DxjVDABe1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Platinum Bank</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">145,436</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RestrictedCashAndCashEquivalents_iI_hus-gaap--RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis__custom--DeerwoodBankMember_zzMIQi3QSGi2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deerwood Bank</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,040,937</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RestrictedCashAndCashEquivalents_iI_hus-gaap--RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis__custom--FirstCitizensMember_zlpvPpiji2R4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">First Citizens</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">222,639</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--RestrictedCashAndCashEquivalents_iI_hus-gaap--RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis__custom--OtherMember_z6P7FFkST2w2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,469</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20231231_zGB1S0UtVrpa" style="border-bottom: Black 2.5pt double; text-align: right" title="Restricted cash and cash equivalents total">2,487,481</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zd6pS70cclxd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company performs ongoing credit evaluations of its customers. In certain circumstances, the Company may require letters of credit, other collateral or additional guarantees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2487481	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	200000	usd
CY2021Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	280903	shares
CY2023	us-gaap	Depreciation Depreciation	10289	usd
CY2022	us-gaap	Depreciation Depreciation	10479	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24759	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18441	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.072	pure
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	273999	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	23048	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-3211000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1615167	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1515000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	834060	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	689159	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	63359	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	115739	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	305747	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	208964	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	48875	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	211658	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	452519	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1463699	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1466381	usd
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-2994584	usd
CY2023	SBET	Monthly Salary Percentage MonthlySalaryPercentage	0.0833	pure
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	0	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	342000	usd
CY2023Q4	us-gaap	Deposits Deposits	0	usd
CY2022Q4	us-gaap	Deposits Deposits	279000	usd
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1137732	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14293676	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15242240	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2760970	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2760970	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2487960	shares
CY2023	SBET	Marketing And Advertising Expense Continuing Operations MarketingAndAdvertisingExpenseContinuingOperations	675496	usd
CY2023	SBET	Marketing And Advertising Expense Discontinued Operations MarketingAndAdvertisingExpenseDiscontinuedOperations	176224	usd
CY2022	SBET	Marketing And Advertising Expense Continuing Operations MarketingAndAdvertisingExpenseContinuingOperations	514087	usd
CY2022	SBET	Marketing And Advertising Expense Discontinued Operations MarketingAndAdvertisingExpenseDiscontinuedOperations	13093	usd
CY2023Q4	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	414819	shares
CY2022Q4	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	288914	shares
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11248598	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14095646	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-11299092	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-14104508	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2487960	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.09
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.09
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-5.67
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-5.67
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.08
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.08
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.46
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.46
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.17
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.17
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.13
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zIauTDPUXF5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zoHgOOvLgdb3">Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Our most critical estimates include those related to the use of the acquisition method of accounting for business combinations, intangibles and long-lived asset impairments, goodwill and impairment, convertible debenture fair value, stock based compensation, discontinued operations and revenue recognition. On an ongoing basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11248598	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14095646	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	582887	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5937386	usd
CY2023	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	22500000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	14836625	usd
CY2023	SBET	Convertible Debenture Percentage ConvertibleDebenturePercentage	1.10	pure
CY2023Q4	SBET	Financing Receivables Accrued Interest After Allowance For Credit Loss FinancingReceivablesAccruedInterestAfterAllowanceForCreditLoss	4484230	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1166824	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	998712	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	168112	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1740050	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	901587	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	838463	usd
CY2023Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	849565	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	97125	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	901587	usd
CY2021Q4	us-gaap	Goodwill Goodwill	3130167	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1515000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1615167	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1615167	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1615167	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10122	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	645571	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1424908	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	645571	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	672471	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	700256	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	62303	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2080601	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	400000	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	1230234	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	116667	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1174229	usd
CY2023	SBET	Amortization Of Debt Discount AmortizationOfDebtDiscount	342482	usd
CY2023	SBET	Incremental Share Adjustments To Accumulated Deficit And Additional Paid In Capital IncrementalShareAdjustmentsToAccumulatedDeficitAndAdditionalPaidInCapital	16486	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	266667	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	45.00
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	880000	shares
CY2023Q2	SBET	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	266667	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	400359	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.82
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y9M29D
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Previously Issued Regular Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionPreviouslyIssuedRegularWarrants	-266667	shares
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Previously Issued Regular Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePreviouslyIssuedRegularWarrants	-45.00
CY2023	us-gaap	Debt Instrument Convertible If Converted Value In Excess Of Principal DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal	4400000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	419048	usd
CY2023Q4	SBET	Warrant Discount WarrantDiscount	831746	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	283335	usd
CY2023	SBET	Accrued Interest On Convertible Debenture AccruedInterestOnConvertibleDebenture	299648	usd
CY2023	SBET	Gain Loss In Fair Value Of Convertible Debenture GainLossInFairValueOfConvertibleDebenture	-1230234	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	4395753	usd
CY2023	SBET	Schedule Of Significant Unobservable Inputs And The Related Expenses And Losses ScheduleOfSignificantUnobservableInputsAndTheRelatedExpensesAndLosses	<p id="xdx_89E_ecustom--ScheduleOfSignificantUnobservableInputsAndTheRelatedExpensesAndLosses_z1d3d26tLtdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zCJmYIM9zs06" style="display: none">Schedule of Significant Unobservable Inputs (level 3) and Related Expenses and Losses</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20230101__20231231_zgrJbycoXYUd" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ConvertibleDebtCurrent_iS_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6lGvs2iUv77" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair Value, December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1499">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfDebt_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z7AHb2Kan407" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Issuance of convertible debenture</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,825,771</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AccretionForDiscountForWarrants_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_znc4QtjbbfQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accretion for discount for warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">342,481</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccretionForOriginalIssuanceDiscount_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTZ7LiNdD0sd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accretion for discount for OID</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">116,667</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InterestExpenseDebt_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWCioW40R1vi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">299,648</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RepaymentsOfConvertibleDebt_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTIbsgQfq0J4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Principle payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(419,048</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--LossOnChangeInFairValue_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zhc7W70ppxNc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,230,234</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleDebtCurrent_iE_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zwE228MhcwH1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Fair Value, December 31, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,395,753</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.500	pure
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y10M24D
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	48633	usd
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Options Acquired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAcquiredInPeriod	14552	shares
CY2023	SBET	Share Based Compensation Arrangements By Share Based Payment Award Options Acquired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInPeriodWeightedAverageExercisePrice	14.16
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2032-12-21
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	178357	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.60
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	830250	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	249650	shares
CY2022	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Previously Issued Regular Warrants Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsPreviouslyIssuedRegularWarrantsWeightedAverageRemainingContractualTerms	P0Y5M4D
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Revalued Regular Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionRevaluedRegularWarrants	266667	shares
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Revalued Regular Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageRevaluedRegularWarrants	0.60
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Revalued Regular Warrants Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsRevaluedRegularWarrantsWeightedAverageRemainingContractualTerms	P0Y5M4D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	125359	shares
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisedDateFairValue	0.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	883015	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.15
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Issued And Vested Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsIssuedAndVestedWeightedAverageRemainingContractualTerms	P3Y1M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1158015	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.43
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y6M29D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	400359	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	400359	shares
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	114000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	36000	shares
CY2022	SBET	Number Of Ordinary Shares With Respect To Which Options May Be Granted Thereunder To Any Eligible Employee Deemed NumberOfOrdinarySharesWithRespectToWhichOptionsMayBeGrantedThereunderToAnyEligibleEmployeeDeemed	78000	shares
CY2022	SBET	Number Of Ordinary Shares With Respect To Which Options May Be Granted Thereunder To Any Eligible Employee Deemed Dividend Expired NumberOfOrdinarySharesWithRespectToWhichOptionsMayBeGrantedThereunderToAnyEligibleEmployeeDeemedDividendExpired	36000	shares
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1655506	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	634367	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2486152	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	372994	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	548459	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.535	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.166	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.511	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.537	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	288914	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.40
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7750	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	155755	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.46
CY2023	SBET	Share Based Compensation Arrangement By Share Based Payment Award Options Acquired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAcquiredInPeriod	14552	shares
CY2023	SBET	Share Based Compensation Arrangements By Share Based Payment Award Options Acquired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAcquiredInPeriodWeightedAverageExercisePrice	14.16
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	42989	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.99
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1413	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.84
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	414819	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.79
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3750	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	660594	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.59
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P6Y10M24D
CY2023Q4	SBET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableOutstandingWeightedAverageRemainingContractualTerm2	3750	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.00
CY2022	SBET	Weighted Average Grant Date Fair Value Grant WeightedAverageGrantDateFairValueGrant	5.20
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	100779	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	54.60
CY2022	SBET	Weighted Average Grant Date Fair Value Forfeited WeightedAverageGrantDateFairValueForfeited	25.60
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	38315	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	63.70
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	288914	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.40
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7750	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	86673	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.60
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P8Y8M12D
CY2022Q4	SBET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableOutstandingWeightedAverageRemainingContractualTerm2	7750	usd
CY2022Q1	SBET	Exchange Ratio ExchangeRatio	1.3352	pure
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	630473	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1009269	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	166544	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4952725	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3420062	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8893202	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11248598	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3489948	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2173835	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-14282838	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14095646	usd
CY2023	us-gaap	Revenues Revenues	4952725	usd
CY2022	us-gaap	Revenues Revenues	3489948	usd
CY2023	us-gaap	Revenues Revenues	4952725	usd
CY2022	us-gaap	Revenues Revenues	3489948	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	415119	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	440873	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	12000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	12000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5786541	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3855779	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	30429	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	30429	usd
CY2023Q4	SBET	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	76059	usd
CY2022Q4	SBET	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	66209	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1402	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	601	usd
CY2023Q4	SBET	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	590235	usd
CY2022Q4	SBET	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	269101	usd
CY2023Q4	SBET	Deferred Tax Assets Capitializations DeferredTaxAssetsCapitializations	70437	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1043615	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	840034	usd
CY2023Q4	SBET	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	103947	usd
CY2022Q4	SBET	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	78560	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7702665	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5140713	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7709820	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5146919	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7155	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6206	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	29000000	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Various ownership changes were considered in this analysis through December 31, 2023 and determined only one change resulted in a greater than 50% ownership change, on July 27, 2021. The amount of SharpLink, Inc.’s NOL carryforward subject to Section 382 limitations is $5.9 million. The resulting annual base limitation on the carryforwards utilization is $1.4M, this limitation does not include potential net unrealized built in gain or loss from IRC Section 382(h) and Notice 2003-65. The Company anticipates the amount of NOL carryforward available to offset the 2024 Q1 gain is $4.9 million, without regards to potential net unrealized built in gain or loss from IRC Section 382(h) and Notice 2003-65, that adjustment is anticipated to increase the available NOL.
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	15708	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	-12955	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15708	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-12955	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2358907	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2908680	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-141084	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-59374	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005	pure
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	21510	usd
CY2023	SBET	Effective Income Tax Rate Meals And Entertainment Nondeductible Expenses And Taxexempt Income EffectiveIncomeTaxRateMealsAndEntertainmentNondeductibleExpensesAndTaxexemptIncome	-0.001	pure
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	25826	usd
CY2022	SBET	Effective Income Tax Rate Meals And Entertainment Nondeductible Expenses And Taxexempt Income EffectiveIncomeTaxRateMealsAndEntertainmentNondeductibleExpensesAndTaxexemptIncome	-0.001	pure
CY2023	SBET	Income Tax Reconciliation Income Tax Effects Allocated Directly To Equity Employee Stock Options Expense IncomeTaxReconciliationIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptionsExpense	69214	usd
CY2023	SBET	Effective Income Tax Rate Incentive Stock Option Expense EffectiveIncomeTaxRateIncentiveStockOptionExpense	-0.001	pure
CY2022	SBET	Income Tax Reconciliation Income Tax Effects Allocated Directly To Equity Employee Stock Options Expense IncomeTaxReconciliationIncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptionsExpense	52306	usd
CY2022	SBET	Effective Income Tax Rate Incentive Stock Option Expense EffectiveIncomeTaxRateIncentiveStockOptionExpense	-0.001	pure
CY2023	SBET	Effective Income Tax Rate Nondeductible Goodwill Impairment EffectiveIncomeTaxRateNondeductibleGoodwillImpairment	-0.082	pure
CY2022	SBET	Effective Income Tax Rate Nondeductible Goodwill Impairment EffectiveIncomeTaxRateNondeductibleGoodwillImpairment	0.000	pure
CY2023	SBET	Income Tax Reconciliation Nondeductible Debt Expenses IncomeTaxReconciliationNondeductibleDebtExpenses	417696	usd
CY2023	SBET	Effective Income Tax Rate Nondeductible Debt Expenses EffectiveIncomeTaxRateNondeductibleDebtExpenses	-0.088	pure
CY2022	SBET	Effective Income Tax Rate Nondeductible Debt Expenses EffectiveIncomeTaxRateNondeductibleDebtExpenses	0.000	pure
CY2023	SBET	Income Tax Reconciliation Estimate Of Cancellations IncomeTaxReconciliationEstimateOfCancellations	6690	usd
CY2023	SBET	Effective Income Tax Rate Reconciliation Nqo Cancelations EffectiveIncomeTaxRateReconciliationNQOCancelations	-0.000	pure
CY2022	SBET	Income Tax Reconciliation Estimate Of Cancellations IncomeTaxReconciliationEstimateOfCancellations	499435	usd
CY2022	SBET	Effective Income Tax Rate Reconciliation Nqo Cancelations EffectiveIncomeTaxRateReconciliationNQOCancelations	-0.000	pure
CY2023	SBET	Income Tax Reconciliation Financial Statements True Up IncomeTaxReconciliationFinancialStatementsTrueUp	2866	usd
CY2023	SBET	Effective Income Tax Rate Financial Statements True Up EffectiveIncomeTaxRateFinancialStatementsTrueUp	0.000	pure
CY2022	SBET	Effective Income Tax Rate Financial Statements True Up EffectiveIncomeTaxRateFinancialStatementsTrueUp	0.000	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	43145	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1954578	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.043	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2377532	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.043	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15708	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.000	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12955	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q4	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	889380	shares
CY2022Q4	us-gaap	Debt Securities Held To Maturity Purchase DebtSecuritiesHeldToMaturityPurchase	5387850	usd
CY2022Q4	us-gaap	Share Price SharePrice	2.90
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1267199	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	4120651	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2500000	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.60
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3130401	shares

Files In Submission

Name	View Source	Status
0001493152-24-012028-index-headers.html	Edgar Link	pending
0001493152-24-012028-index.html	Edgar Link	pending
0001493152-24-012028.txt	Edgar Link	pending
0001493152-24-012028-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
ex97-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sbet-20231231_cal.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbet-20231231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sbet-20231231_def.xml	Edgar Link	unprocessable
sbet-20231231_pre.xml	Edgar Link	unprocessable
sbet-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBET
SharpLink Gaming, Inc. Stock $sbet

2024 Q1 Form 10-K Financial Statement

#000149315224012028 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBET SharpLink Gaming, Inc. Stock $sbet

2024 Q1 Form 10-K Financial Statement

#000149315224012028 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBET
SharpLink Gaming, Inc. Stock $sbet